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Aggregation of amyloid-β (Aβ) peptides is a significant event
that underpins Alzheimer’s disease (AD). Aβ aggregates,
especially the low-molecular weight oligomers, are the
primary toxic agents in AD pathogenesis. Therefore, there is
increasing interest in understanding their formation and
behaviour. In this paper, we use our previously established
results on heterotypic interactions between Aβ and fatty acids
(FAs) to investigate off-pathway aggregation under the
control of FA concentrations to develop a mathematical
framework that captures the mechanism. Our framework to
define and simulate the competing on- and off-pathways of
Aβ aggregation is based on the principles of game theory.
Together with detailed simulations and biophysical
experiments, our models describe the dynamics involved in
the mechanisms of Aβ aggregation in the presence of FAs to
adopt multiple pathways. Specifically, our reduced-order
computations indicate that the emergence of off- or
on-pathway aggregates are tightly controlled by a narrow set
of rate constants, and one could alter such parameters to
populate a particular oligomeric species. These models agree
with the detailed simulations and experimental data on using
FA as a heterotypic partner to modulate the temporal
parameters. Predicting spatio-temporal landscape along
competing pathways for a given heterotypic partner such as
lipids is a first step towards simulating scenarios in which
the generation of specific ‘conformer strains’ of Aβ could be
predicted. This approach could be significant in deciphering
© 2020 The Authors. Published by the Royal Society under the terms of the Creative
Commons Attribution License http://creativecommons.org/licenses/by/4.0/, which permits
unrestricted use, provided the original author and source are credited.
the mechanisms of amyloid aggregation and strain generation, which are ubiquitously observed in
many neurodegenerative diseases.
1. Introduction
Aggregation of the protein amyloid-β (Aβ) is one of the central processes in the aetiology of Alzheimer’s
disease (AD). Generated by the proteolytic processing of amyloid precursor protein (APP), Aβ peptides
(Aβ40 or Aβ42) spontaneously aggregate to form insoluble fibrils that deposit as senile plaques in the AD
brain. During aggregation, the low-molecular weight oligomers formed are known to be the primary
toxic species responsible for synaptic dysfunction and neuronal loss [1–6]. An increasing number of
reports indicate that structural polymorphism and heterogeneity within the aggregates could
contribute to clinical phenotypes observed among AD patients [7,8]. Therefore, over the last decade,
significant efforts are focused on understanding the biophysical and biochemical aspects of
aggregation as well as the molecular understanding of the aggregates.
Aβ aggregation follows a nucleation-dependent, sigmoidal growth kinetics involving a key rate-
limiting event of nucleus or nuclei formation [9–13]. Since the nucleation plays an important role in
determining the morphology of the fibrils formed, the dynamics associated with reactions leading
up to nucleation are critical determinants of aggregation. In this regard, the sensitivity of Aβ to
environmental factors and many interacting partners due to its intrinsic disorder and amphipathic
nature [14–18] play a key role in Aβ adopting multiple pathways depending on the aggregation
conditions. An important ramification of this is that the oligomers may not be obligate intermediates
of fibril formation but those with distinct conformations can be formed along alternative aggregation
pathways (off-pathways) [13,19–23]. This is significant because such interactions, depending on the
structure of the oligomer, determine the morphology of the aggregates formed and consequently, the
toxicity and phenotypes.
Therefore, it is imperative to gain an understanding of how physiological interacting partners of Aβ
affect its aggregation dynamics. Being generated from the membrane-spanning domain of the APP, Aβ
displays synchronous and perpetual interaction with membrane lipids [24–30]. Interfaces of lipids and
fatty acids (FAs) are also abundant in both cerebral vasculature and cerebral spinal fluid (CSF) [31,32].
Previous reports have established that phase transitions of surfactants and membrane lipids modulate
Aβ aggregation in a concentration-dependent manner to generate aggregates by an alternative, off-
pathway from the canonical fibril formation, on-pathway [13,16,20,33–37]. Specifically, in micellar
lipids, low-molecular weight oligomers were generated along off-pathway in the presence of fatty acid
near and above their respective critical micelle concentrations (CMC) (pseudo-micellar and micellar,
respectively) and not below CMC (non-micellar) which augmented the fibril formation in the on-
pathway [16,34,38].
The modulation of aggregation by heterotypic interactions between Aβ and lipids posit the question
of what spatio-temporal parameters govern the modulatory dynamics, and whether one could simulate
the temporal emergence and disappearance of aggregates as a function of heterotypic Aβ-lipid
interactions. In this work, we have approached to answer these questions using a competition-based
(built qualitatively upon the idea of game theory) approach to determine the dynamics in the
temporal evolution of Aβ aggregates along the pathways influenced by fatty acid surfactants (L). Our
rationale for such an approach is that the stochasticity and the often exclusive pathways of Aβ
aggregation present ‘win or loss’ scenarios with respect to pathway adoption, tightly governed by the
concentration and phase transitions of L. The mathematical analysis of this problem was taken up in
two layers, one feeding into the other. The first is a six species, coarse-grained, reduced-order model
(ROM), while the second is a more detailed model called ensemble kinetic simulation (EKS), which
captures the temporal kinetics of reactions at the atomistic scale (considered as point particles). The
ROM approach lends itself to a detailed analysis in a manner that cannot be performed in high-
resolution models as we have shown before [34,39]. Phenomenologically inspired by the biophysical
framework, and using toy models, ROM provides insights into the dynamics of mechanism that are
previously unknown. In addition, the outcomes of the ROM analysis provide the appropriate cues to
investigate the mechanism deeper with the EKS models. These models are partly validated by bulk
kinetic and thermodynamic features using biophysical experiments. The simulations, supported by
biophysical analyses, provide a temporal contour map along competing pathways, and present a
unique perspective on otherwise unknown evolution of aggregates along multiple pathways.
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2. Material and methods
2.1. Reduced-order kinetic modelling
The model presented here consists of a reduced order, comprising only six species of Aβ that interact with
the fatty acid surfactant, L. Even with just six species, there are infinitely many rate regimes, most of
which would be physically inconsequential. Thus, only physically meaningful rate regimes suggested
from experiments and our previous studies [34,39] were chosen, and key parameters were varied to
understand the dynamics. Specifically, two models were considered: (i) the base model, where the
forward rate constants to back constants were taken to be 1000, and (ii) a second ‘pathological’ model,
where the forward and backward reactions are taken to be identical. The second model has no known
physical basis; however, it can be considered as a sort of parameter sensitivity study and an extreme
case when the physiological process breaks down.
A schematic of such a model is presented below (see also figure 1). In this model, Aβmonomers react
with the pseudo-micellar fatty acid surfactants, L to modulate the formation of on- or off-pathway
aggregates. The system of chemical reactions in our model consists of the following:
A1 þ L !
kþ1
k1
A01,
nA1  !
kþ2
k2
An,
nA01  !
kþ3
k3
A0n,
An þ L !
kþ4
k4
A0n,
m
n
An  !
kþ5
k5
Am
and
m
n
A0n  !
kþ6
k6
A0m:
The non-prime species, A1, An and Am represent on-pathway Aβ monomers (A1) and oligomers
(An and Am where m is an integral multiple of n); whereas the prime species, A01, A
0
n and A
0
m, are the
corresponding off-pathway species which are generated through a reaction with the pseudo-micellar
surfactant, L. The rate constants k+i (i = 1–6) are indicated in the reaction schematic above where the
‘+’ represents a forward rate and ‘−’, a backward rate. These reactions were formulated based on
experimental evidence demonstrated earlier [40]. In the computations to follow, for each species, n = 4
and m = 20 unless otherwise specified, which denotes the order of oligomer [33]. The n, m values in
the computations were kept low to minimize computational time. This is also because only significant
qualitative features in the system were being sought by ROM, and a more fine-grained approach by
L + B1 B¢1
B¢n
B¢m
L + Bn
Bm
a3
a4
a2 b1
b4
b3 b5
b2
a6a5
a1
on off
1
Figure 1. Schematic of on- and off-pathway aggregation model based on the six-species reaction scheme described earlier.
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EKS modelling provides atomistic temporal analyses using the output from ROM. However, it must be
noted that the key results of the study were examined for different values of n and m to ensure qualitative
similarities and with no loss of generality as shown previously [34].
The reaction scheme was used to develop the corresponding kinetic model comprising a system of six
nonlinear differential equations. This system was then put into non-dimensional form. Using A0 as the
characteristic concentration of monomers and 1=k1 the characteristic time, the dimensionless species
are defined as follows:
B1 ¼ A1A0 ; Bn ¼
An
A0
; Bm ¼ AmA0 ; B
0
1 ¼
A01
A0
; B0n ¼
A0n
A0
; B0m ¼
A0m
A0
:
The reaction constants are similarly defined as follows:
a1 ¼ k

2
k1
; a2 ¼ k
þ
2 A
n1
0
k1
; a3 ¼ k
þ
1 L
k1
; a4 ¼ k
þ
4 L
k1
; a5 ¼ k

5
k1
; a6 ¼ k
þ
6 A
ðm=nÞ1
0
k1
and
b1 ¼
k3
k1
; b2 ¼
kþ3 A
n1
0
k1
; b3 ¼
kþ5 A
ðm=nÞ1
0
k1
; b4 ¼
k4
k1
; b5 ¼
k6
k1
:
Note that both α3 and α4 have a factor L which is responsible for off-pathway aggregation. These two
parameters serve as the bridge variables between on- and off-pathway species. Using the law of mass
action kinetics, the dimensionless system of differential equations was formulated as follows:
dB1
ds
¼ na1Bn  na2Bn1 þ B01  a3B1, ð2:1Þ
dB01
ds
¼ nb1B0n  nb2B0n1 þ a3B1  B01, ð2:2Þ
dBn
ds
¼ a2Bn1  a1Bn þ
m
n
a5Bm þ b4B0n  a4Bn 
m
n
b3B
m=n
n , ð2:3Þ
dB0n
ds
¼ b2B0n1  b1B0n þ a4Bn þ
m
n
b5B
0
m 
m
n
a6B0m=nn  b4B0n, ð2:4Þ
dBm
ds
¼ b3Bm=nn  a5Bm ð2:5Þ
and
dB0m
ds
¼ a6B0m=nn  b5B0m: ð2:6Þ
As stated earlier, primarily two models referred to as the Base Model and Model 2 were analysed,
which are distinguished by the choice of fixed parameter values; i.e. the rate constant ratios in the
pure on- and off-pathways. In the Base Model, all forward rates (α1, α2, α5, α6) and all backward rates
(β1, β2, β3, β4, β5) were set to 1 and 0.001 based on previous mathematical models and experimental
data [39,40]. In the context of the Base Model, a forward rate is defined as one that converts a smaller
oligomer into a larger aggregate, and backward being the reverse process. It must be noted that since
ROM is a bulk averaged model, precise one-to-one mapping of its rate constants to that of the
detailed EKS model is neither practical nor meaningful. In Model 2, all forward and backward rates
were set to unity. Ode 45 solver (Matlab) was used for our numerical computations.
A convenient approach to the problem would be to analyse the model equations (2.1)–(2.6) from a
game-theoretic point of view. Such an approach warrants finding the conditions under which the
triplet (B1, Bn, Bm) are greater, less or equal to (B01, B
0
n, B
0
m) respectively; equality would indicate the
Nash equilibrium. A similar game-theoretic treatment was applied to a simpler system in our earlier
work on multiple-pathway protein aggregation [34], and also by others on various biochemical
systems [41–43]. In the context of amyloid protein aggregation, the current model system shows the
emergence of new states discussed in detail in §3.1.3, which have previously not been observed and
lead to new experimental questions about dominant chemical reaction fluxes in competing systems.
2.2. Ensemble kinetic simulation
Detailed insights into the switching behaviour between on- and off-pathways were formulated by a
combined off–on-pathway EKS model. EKS model has previously been applied for Aβ aggregation
system [11,12,34,39,44–46]. In this paper, we have extended our previous work by adding switching
royalsocietypublishing.org/journal/rsos
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reactions considering off-to-on and on-to-off oligomer conversion. It has to be borne in mind that the
switching reactions only take effect from perturbation events such as changes in the concentrations of
pseudo-micellar fatty acid, L [16].
In the EKS model, a set of reactions was considered to represent the on-pathway, off-pathway and
their switching, and the flux for each reaction was computed. The system of differential equations of
each species present in the reaction system were identified and solved using the ODE 23s solver
(Matlab). The following is the reaction scheme considered (corresponding differential equations are
presented in Appendix C):
I. Reactions of on-pathway: (considering A12 as F):
A1 þ Ai  !knu
knu
Aiþ1; 8i [ {1,2, . . . ,11}
and
Fþ Ai  !kel
kel
F; 8i [ {1,2, . . . ,11}:
II. Reactions of off-pathway model:
4 A1 þ L !kcon
kcon
A04,
A0i þ A1  !
knuf
knuf
A0iþ1; 8i [ {4, . . . ,11},
A012 þ A0i  !
kel1f
kel1f
F01; 8i [ {4, . . . ,11},
F01 þ F0i  
kel2f
kel2f
F0iþ1; 8i [ {1, . . . ,3}
and F04  !
kfagf
kfagf
4F001 :
III. On-to-off switching reaction:
A0i  !
kswi
kswi
Ai:
The corresponding flux for the reactions is given as follows:
I. On-pathway reactions flux:
Hi ¼ knu[Ai][A1] knu [Aiþ1]; 8i [ {1,2, . . . ,11}
Ii ¼ kel[Ai][F] kel [F]; 8i [ {1,2, . . . ,11}:
II. Off-pathway reactions flux:
G01 ¼ kcon[A1]4[L] kcon [A04],
H0i ¼ knuf[A0i][A1] knuf [A01þi]; 8i [ {4, . . . ,11},
I0i ¼ kel1f[A0i][A012] kel1 [F01]; 8i [ {4, . . . ,11},
P0i ¼ kel2f[F0i][F01] kel2 [F0iþ1]; 8i [ {1, . . . ,3}
and R01 ¼ kfagf[F04] kfagf [F001]4:
III. Switching flux:
Si ¼ kswi[A0i] kswi [Ai]:
Here, and in Appendix C, Ai denotes an on-pathway i-mer, A0i denotes an off-pathway i-mer, L
denotes pseudo-micellar surfactants, F denotes post-nucleation on-pathway aggregates (here A12 is
considered equivalent to F which corresponds to an on-pathway nucleus of 12mer as previously
reported [40]; F for the sake of simplicity), F0i is an off-pathway oligomer, signal is the total thioflavin-T
(ThT) fluorescence intensity which is expressed as the sum of the on-pathway ThT signal (signalon)
and the off-pathway ThT signal (signaloff ) (as shown in Appendix B; this uses an arbitrary mapping
constant to map the total oligomer concentration to the experimentally observed ThT signal intensity).
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Note that in the EKS models, we consider the most general case where there can be switching between
any on- or off-pathway oligomer of size A1 to A11. Similarly, smaller off-pathway oligomers from A016–A
0
23
were considered as F01 and larger off-pathway oligomers were considered as F
0
iði ¼ 1, . . . ,4Þ while a
dissociation of F04 was considered to lead to the formation of F
00
1, which is a kinetically trapped off-
pathway oligomer that does not aggregate further. The existence of such on- and off-pathway
oligomers and the validity of our combined on- and off-pathway model (barring the switching
reaction) have already been established in earlier work [34,47].
2.3. Biophysical analysis
Synthetic, wild-type Aβ42 procured from both Peptide 2.0 and Dr Chaterjee’s laboratory at the University
of Mississippi was used in this study. ThT, sodium dodecyl sulfate (SDS) and lauric acid (C 12:0) was
purchased from Sigma–Aldrich (St Louis, MO). Monoclonal Ab9 or Ab5 antibodies were obtained
from the University of Florida Center for Translational Research in Neurodegenerative Diseases.
2.3.1. Protein preparations
Preparation of Aβ42 monomers: Aβ42 peptide (1–1.5 mg) that was kept desiccated at −20°C was dissolved
in 50 mM NaOH and was allowed to stand at room temperature for up to 45 min. The dissolved peptide
was then fractionated on a Superdex-75 HR 10/30 size exclusion chromatography (SEC) column (GE Life
Sciences) on a BIORAD FPLC system that was pre-equilibrated with 20 mM Tris at pH 8.00, to separate
any preformed aggregates as previously reported [41]. Fractions were collected at a flow rate of
0.5 ml min−1 and stored at 4°C and were used within 24 h to avoid reaggregation. The concentration
of the monomeric fractions was calculated using a Cary 50 UV–Vis spectrophotometer (Varian Inc.).
The molar extinction coefficient of 1450 cm−1 M−1 at 276 nm was used (www.expasy.org).
On- and off-pathway aggregation reactions: On-pathway aggregation was initiated with 40 µM
monomeric Aβ42 in 20 mM Tris–HCl, 50 mM NaCl at pH 8.0 incubated under quiescent conditions at
37°C with 0.01% NaN3. Off-pathway reactions were initiated using 25 µM monomeric Aβ42 in the
same buffer incubated with 50 mM NaCl and 5 mM sodium laurate (C12 FA) in 20 mM Tris, pH 8.00,
as reported previously [16,34].
2.3.2. ThT fluorescence aggregation assay
For on-to-off-pathway switching reactions, to 150 µl, 50 µM Aβ reactions incubated in buffer alone, a
50 µM ThT solution in the same buffer was added and fluorescence emission (λ = 482 nm) was
collected using microplate reader (BioTek Synergy Microplate Reader) at 37°C using an excitation at
452 nm. A 5 mM sodium laurate (C12 fatty acid) sample pre-equilibrated with 50 µM ThT was added
to the reactions at 3, 8 and 24 h to initiate switching of pathways. The data were collected at 10 min
time intervals. For off-to-on-pathway switching reactions, the 150 µl, 50 µM Aβ reactions pre-incubated
in the presence of 5 mM sodium laurate were diluted 5- or 10-fold at 5 and 10 h using buffered 50 µM
Aβ monomers and 50 µM ThT such that only the fatty acid concentration is dropped below its CMC.
Appropriate blank reactions were monitored simultaneously and were corrected before data processing.
2.3.3. SDS–PAGE and immunoblotting
Aliquots of the reactions were mixed with sample buffer comprising 1% SDS (1× Laemmli sample buffer)
and loaded on a precast 4–12% Bio-Rad gel. For calibration, pre-stained molecular weight markers
(Invitrogen Inc.) were used. The gels were then electroblotted on 0.45 µm nitrocellulose membrane
(GE Life Sciences). The blots were then heated in the microwave for 1 min and were blocked with 5%
non-fat dry milk solution with 1% Tween-20 in PBS for 1.5 h. Subsequently, the blots were probed
with monoclonal antibody Ab5 or Ab9 (1 : 1000–1 : 2500 dilutions) which bind to residue 1–16 of Aβ.
Anti-mouse horseradish peroxide was added to the blot and the blot was developed with ECL
reagent (Thermo Fisher Scientific) and imaged with a Bio-Rad Gel Doc system.
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3. Results
3.1. Reduced-order model indicates switching behaviour between pathways is dictated by the
dynamics of equilibrium stability and bridging
3.1.1. Steady states
In order to study the stability of the system, bulk rate constants obtained from experiments were used to
determine steady state, or concentration at a given time-point [39]. One is especially interested in the non-
zero terminal states of each species. Numerical computations indicate that concentration of species
continues to change over time for our models, heading towards the steady state. However, in all cases
these changes were within 0.1% of previous levels for t greater than some critical time, which was
considered acceptable as equilibrium. The equilibrium values were also confirmed through Matlab’s
fsolve function. In all ROM computations discussed in this paper, the initial conditions were taken to
be B1(0) = 1 with all other species set initially at zero. As seen from figure 2a and b, as time increased,
the concentration levels exhibited asymptotic behaviour and each species eventually achieved
equilibrium. The time to reach this steady state was sensitive to the choice of rate constants; the Base
Model took longer to reach steady state than the Model 2. Also, in all cases analysed the fibril
concentrations Bm and B0m took the longest to reach equilibrium.
Due to low forward rates, the concentration size of B1 stayed high and stable throughout, but large
percentage changes in the concentration of B0m were observed periodically. Analysis of the concentration
patterns of both B1 and B0m over this period revealed that their growth and decline patterns are a
reciprocal image of one another: periods of increase in B1 were accompanied by decline in B0m. From
the equilibrium analysis of these models, it was discovered that when the ratio of backward to
forward rates is close to 1, the model settles at equilibrium more quickly than when the ratio is large
(figure 2c). A power-law regression indicates that time to equilibrium (indicated by teq) varies with
the ratio of forward to backward rates (r) according to teq∝ r−0.615.
0.8
0.4
co
n
ce
n
tr
at
io
n
0
0 5 10
backward/forward ratio
0.0001 5190
2200
595
105
20
0.001
0.01
0.1
1
equilibrium time
time
15 20 0 5 10
time
15 20
0.8
0.4
0
B¢1
B¢n
B¢m
B1
Bn
Bm
B¢1
B¢n
B¢m
B1
Bn
Bm
(b)(a)
(c)
Figure 2. Panels (a) and (b) show sample solutions of the Base Model and Model 2 corresponding to equations (2.1)–(2.6) for the
ROM. The different colours in both panels correspond to the evolution of the six different species, indicated in the figure legend.
Panel (c) depicts a table showing the equilibrium time as a function of the ratio of backward to forward rates for the Base Model.
Clearly, as the ratio of backward to forward rate constants increase, as in pathological cases, the time to equilibrium decreases.
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The impact of varying n and m in both models was also investigated. In these cases, increasing n and
m increased teq but yielded similar qualitative results, some of which are also discussed in Appendices A
and B. It appears that the larger the oligomer size, the higher the power of the nonlinear terms in the
governing equations, the greater the potential for over- and under-shoot as the model evolves over
time. Thus, it takes longer to achieve equilibrium. However, Model 2 does not show an increase in teq
as noted earlier.
3.1.2. Bridge parameters
The key parameters in our model are α3 and α4 which are referred to as ‘bridge’ or control parameters,
and they govern the reaction dynamics between on- and off-pathway. The effect of varying both on
species formation was verified while holding all other reaction rates constant (figure 3). When
increasing both α3 and α4, a direct increase in the ratio of off-pathway species to on-pathway species
was observed. Since B0m=Bm is not directly governed by the bridge variables, it was slower to react to
changes along the bridges, but eventually exhibited what appears to be exponential growth at higher
values of the bridge variables (figure 3a). This is probably due to the fact that B0m formation is
dependent upon α3 and α4, so that increasing α3 and α4 eventually impacts B0m.
Figure 3a and b underscores the importance of the bridge variables. Interestingly, if α4 was left
unchanged and α3 was increased, there was limited flow-through from B01 to B
0
n and B
0
m: their ratios to
the non-prime species increased slightly above unity, but ceased to grow from there on even as α3
continued to increase. Therefore, this suggests that the bridge reaction Bn $ B0n is critical in the
formation of the larger oligomers, i.e. the n and m species. The ROM modelling, therefore, reveals that
bridges between larger oligomers are more significant than the ones across monomers in terms of
promoting off-pathway fibril formation. Additional tests were performed to verify conditions for any
species to outperform others by appropriate choice of the rate constants. Forcing B1 to outperform, for
instance, is just a matter of reducing or shutting off all the forward reactions. For species further
down the reaction-network, forward reactions were required to increase to get the desired out-
performance. In the case of B0m, out-performance of this species was obtained in absolute terms by
increasing the forward reaction rates α3, β2 and α6 by an order 10
4. Out-performance by Bm could also
be achieved in a similar manner. Such an exercise can be significant in helping to identify pathogenic
aggregates and shows the robustness of the network under standard reaction rates.
3.1.3. A ‘game-theoretic’ approach to understanding pathways
Figure 4d provides a schematic of the four equilibrium pathways that our model can achieve, each sensitive
to the choices of parameters α3 and α4. In figure 4a, the first schematic highlighted in red is strictly on-
pathway, where the non-prime species ‘win’. The next highlighted in blue is strictly off-pathway, where
all off-pathway species wins. The paths indicated in yellow and green are a mixture of on/off-pathway.
Figure 4d depicts the network graph corresponding to each of the phases. Computations were conducted
10
5
ra
tio
0
0 1 2 3 4 5 6 7 8 9 10
0 1 2 3 4 5 6 7 8 9 10
0 1 2 3 4 5 6 7 8 9 10 0 1 2 3 4 5 6 7 8 9 10
0 1 2 3 4 5 6 7 8 9 10
0 1 2 3 4 5 6 7 8 9 10
10
5
ra
tio
0
2
1
ra
tio
0
10
5
ratio of B¢1/B1
ratio of B¢n/Bn ratio of B¢n/Bn
ratio of B¢m/Bmratio of B¢m/Bm
ratio of B¢1/B1
0
1.005
1
0.995
1.05
1
0.95
a4, a4 a3
(b)(a)
Figure 3. Concentration ratios of like-species between the two pathways as a function of α3 and α4 in the Base Model. Panel (a)
shows these ratios as a function of both the bridge parameters while in panel (b) α3 is varied while holding α4 fixed. This figure
shows the impact of the bridge parameters upon specific oligomers in the reaction pathways, indicating that the bridges between
larger oligomers play a more significant role in the pathway dynamics and competition.
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by varying α3 and α4 between 0 and 2 in increments of 0.02, resulting in 10 000 discrete points. Figure 4a and
b shows a phase diagram for the Base Model and Model 2, respectively.
For the Base Model, (α3, α4) = (1, 1); is a critical point at which the concentrations of on- and off-
pathway species are equal. As α3 and α4 were varied, dominance of one set of species or pathways
over another emerged. Notable too is the fact that the boundaries between the different equilibrium
states were almost linear: the line α4 = 1 determines the switching between on- and off-pathway
dominance of n and m species, and the line α3 = 1 determines the switching between on- and off-
pathway dominance of monomers. The table in figure 4c shows the equilibrium states as a function of
α3 and α4 in the form of a pay-off-like matrix. The Nash equilibrium lies at the point where on-pathway
species concentrations are equal to off-pathway species concentrations.
A similar computation was performed for Model 2 (figure 4b). Here too, (α3, α4) = (1, 1) was a critical
point; however, unlike in the Base Model, it does not strictly define out-performance of B1 over B01 and vice
versa; still B1 outperforming B01 was seen for α3 > 1 and low α4, and B
0
1 outperforming B1 for α3 < 1 and
high α4. The major difference is that the red and blue regions representing the only on-pathway and only
off-pathway, respectively, increased at the expense of green and yellow (mixed pathways).
More importantly, the range of points over which on-pathway wins got bigger when backward rates
were on par with forward rates. For α3 < 1, by increasing β1 and β5, B1!B01 bridge towards off-pathway
aggregation was effectively shut off, hence the increase in red in the upper left of figure 4b. The reverse
happened in the lower right for α4 < 1 as we observed greater off-pathway aggregation up to a point.
Despite increasing α3 above 2, upon reducing α4, a thin band of dominance of Bn and Bm over their
respective primed off-pathway species was continued to be observed. Once again, this shows that the
Bn!B0n bridge is more critical for off-pathway aggregation of n and m species than the monomer-
bridge. If α4 was reduced, an on-pathway dominance of n and m species even for high α3 was still
obtained. Thus, it is difficult to control the off-pathway aggregation of n and m species by tweaking
the B1!B01 bridge.
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Figure 4. Aggregation pathways as a function of α3 and α4. Panels (a) and (b) depict a contour plot of the dominant species as a
function of the bridge parameters for the Base Model and Model 2, respectively. Panel (c) shows the pay-off matrix for panel (a)
depicting the various conditions for domination. Panel (d ) depicts the pathway diagram indicating the dominant sub-path for
specific choices of bridge parameters, corresponding to panels (a) and (b).
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3.2. Biophysical evidence for the switching of aggregation pathways
The effect of FAs on Aβ42 aggregation has been well established in the Rangachari laboratory [13,44,45].
Specifically, using sodium laurate at concentrations near and well above its CMC, the surfactant was able
to modulate Aβ42 aggregation toward off-fibril formation pathway that was populated by low-molecular
weight oligomers. At concentrations well below CMC, the fatty acid adopted an on-fibril formation
pathway [16]. To experimentally assess the switching of pathways from on- to off-pathway and vice versa
by modulating L concentrations, kinetic rate differences in aggregation was investigated using ThT dye.
Switching of on- to off-pathway (depicted schematically in figure 5a) was initiated by the addition of
5 mM C12 FA to 25 µM Aβ42 buffered in 20 mM Tris, 50 mM NaCl at pH 8.0. The addition of C12 FA
resulted in an increase in ThT fluorescence without any observable lag time (black square; figure 5b).
By contrast, Aβ42 in the absence of C12 FA showed a lag phase of approximately 50 h before an
increase in ThT fluorescence was observed (black diamond; figure 5b). This behaviour in the presence
of C12 FA has been previously observed to generate 12–24mer oligomers of Aβ along the off-fibril
formation pathway [48]. In order to evaluate the propensity of bridging from on- to off-pathway,
5 mM C12 FA was added to the control Aβ42 reaction after 0 h (positive control (black square), 3 h
(red circle), 8 h (blue triangle) and 24 h (purple inverted triangle). Each of such incubations resulted in
an exponential increase in ThT fluorescence suggesting switching of pathways from on to off
(figure 5b). Analysis of these samples was also performed using a partially denaturing gel
electrophoresis (low SDS and no boiling) and immunoblotting (figure 5b). Injections of C12 FA at 3
and 8 h show the presence of 48–60 kDa band corresponding to 12mer oligomers (lanes 1 and 2,
respectively) as compared with the corresponding controls generated upon adding buffer in place of
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Figure 5. Experimental verification of switching of pathways. (a) Schematic representation of on-pathway switching (red arrows) of
on-pathway (Bn) to off-pathway (B
0
n and B
0
m) on addition of C12 FA. (b) ThT kinetics of the on-to-off transitions probed
by the introduction of fatty acid at 3 (red circle), 8 (blue triangle) and 24 h (purple inverted triangle) time points, along with
the controls with no fatty acid (green diamond) and with C12 FA introduced at 0 h (black square). (c) Immunoblots for the
corresponding reactions: addition of 5 mM at 3 h (lane 1); addition of 5 mM at 8 h (lane 2); 3, 8 and 24 h buffer controls
(lanes 3–5), and addition of 5 mM at 24 h (lane 6). (d ) SEC fractionation of the reaction before the addition of fatty acid at
24 h (blue), involving the addition of 5 mM C12 fatty acid (black) at 24 h to the sample and control without fatty acid (red),
after subsequent incubation for 24 h at 37°C. (e) Schematic representation for switching of off-pathway ðB0nÞ to on-pathway
(B0n to Bn) on dilution of the fatty acid below its critical micelle concentration ( f ). ThT kinetics monitored by the removal of
5 mM fatty acid on the sample incubated with Aβ by diluting with buffer either 5- (red or purple) or 10-fold (green or blue)
at 5 h (red circle) and 24 h (blue triangle), respectively. The control without dilutions is shown in black; black diamond. (g)
Immunoblot of off-pathway oligomer control generated in the presence of 5 mM fatty acid at 24 h (lane 1); 5- and 10-fold
dilutions at 5 h, respectively (lanes 2 and 3), and 5- and 10-fold dilutions at 24 h, respectively (lanes 4 and 5).
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C12 FA (lanes 3 and 4), which show monomers and some on-pathway aggregates. This suggests that off-
pathway oligomers are generated (figure 5c). Similarly, FA injected after 24 h and its corresponding
control are shown in lanes 5 and 6, respectively, which shows even after 24 h, C12 FA is able to
induce the formation of oligomers to a certain extent, with clearly observable emergence of some on-
pathway fibrils. These results parallel those observed by ThT fluorescence (figure 5b).
To further quantify the extent of bridging, the aggregates generated after the 24 h injection of C12 FA
(or buffer for the control) were fractionated by SEC, after an additional 24 h incubation (figure 5d ). Prior
to fractionation, the samples were centrifuged at 18 000g for 20 min to remove any high molecular weight
fibrils, and the supernatant was loaded on to the column. After 24 h, the control in the absence of C12 FA
shows a small peak near the void volume at fraction 17 and a monomer peak at fraction 24 (blue;
figure 5d ). Fractionation of the control reaction at 48 h (after injection of buffer at 24 h) showed a
diminished peak at fraction 17 and a reduced monomer peak at fraction 24 (red; figure 5d ). The
reduction in the monomer peak correlates to being consumed during aggregation. A similar reduction
in the aggregate peak between 24 and 48 h can be explained by the fact that many have formed fibrils
that are centrifuged out. On the other hand, fractionation of the sample after 48 h with the injection of
5 mM C12 FA at 24 h, showed a larger peak at fraction 18 and a reduced monomer peak at fraction
25 (black; figure 5d ). This suggests two possibilities: (i) the unreacted monomers adopt off-pathway
upon introduction of C12 FA, and/or (ii) the pre-formed aggregates along the on-pathway are re-
routed back through the off-pathway, in other words, switching. More detailed analysis on this is
discussed later in the article.
To assess a similar switching of pathways, we performed the off- to on-pathway (schematically
depicted in figure 5e) switching again using the established C12 FA kinetics. Incubation of 5 mM C12
FA shows an exponential increase in ThT fluorescence (black diamond; figure 5f ). To effect switching
of off- to on-pathway after certain time periods, the sample was diluted 5- and 10-fold such that
the effective concentration of C12 FA drops to 1 and 0.1 mM, which are well below the CMC of the
surfactant. It is well established that well below CMC, Aβ aggregation is augmented [16], and
therefore, dilutions of 5 mM C12 FA must induce faster rates of aggregation. When dilutions were
introduced, at 5 and 24 h time points (arrows; figure 5f ), appropriately blank subtracted data showed
an increase in ThT fluorescence as expected for both dilutions suggesting the switching of off- to
on-pathway (figure 5f ). Partially denaturing gel electrophoresis and immunoblotting further
confirmed the switching. The 5- and 10-fold dilutions resulted in an increase in the molecular weight
of the aggregates including the formation of fibrils both at 5 and 24 h, respectively (lanes 2–5;
figure 5f ) as compared with the sample in 5 mM C12 FA (lane 1).
3.3. Ensemble kinetic simulation models validate the game-theoretic approach in elucidating
the dynamics of competing aggregation pathways
3.3.1. Parameter estimation
As mentioned in the Material and methods section, in the EKS model, four on-pathway rate constants
(namely, knu, knu_, kel, kel_), 10 off-pathway rate constants (namely, kcon, kcon_, knuf, knuf_, kel1f, kel1f_, kel2f,
kel2f_, kfagf, kfagf_) and two off–on switching rate constants were considered (note that the forward and
backward rate constants of switching each oligomer was considered the same, leading to only two
switching parameters that need to be estimated, i.e. kswi, kswi_). Additionally, one needs to estimate two
constants: p (which is simply a mapping constant that distinguishes the contributions of on-pathway
oligomers from off-pathway oligomers to the ThT signal intensity) and pseudo-micelle concentration
(concentration of the fatty acid near its CMC denoted by L). Following our published model in [34], the
pseudo-micelle concentration was additionally estimated and not calculated directly from the FA
concentration values at the CMC, since precise concentrations of pseudo-micelles are difficult to
determine experimentally (only a fraction of total fatty acid concentration) as they are in dynamic
equilibrium with other phases of micelle formation. This increased the number of parameters needed to
be estimated to 18 from the EKS simulations. The potential complication is mitigated by the fact that our
on- and off-pathway rate constants can be estimated separately using the respective control data. This
makes it less cumbersome to estimate the remaining four rate constants (i.e. the two off–on switching
rate constants kswi, kswi_, the mapping constant p and the pseudo-micelle concentration L) from this off-
on switching dataset by significantly reducing the number of free parameters. A large parameter space
from 10−6 to 108 units with multiples of 10, was swept to estimate the value of each of the two switching
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rate constants. Similarly, the pseudo-micelle concentration was varied from 0.01 to 1 units (with steps of
0.01), and p was varied from 105 to 108 units (with steps of 105). The estimated parameter values
corresponding to the best fits are shown in table 2 in Appendix C. The benchmark on- and off-pathway
rate constants (estimated separately from control data), were used to estimate the switching rate
constants and obtain a global fit to the experimental ThT curves and monomer ratio values estimated
from SEC measurements. The average R2 of the off-to-on data is 0.974 and that of on-to-off data is 0.981.
3.3.2. Numerical results
The switching rate constants were sensitive specifically in the off–on dataset. The experimental data
could not be fit in the absence of the switching rate constants and only a handful of switching rate
constant combinations allowed an acceptable fit; the switching rate constants corresponding to the
best fit to the experimental data are reported in table 2 in Appendix C. This directly proves
the switching of off-pathway oligomers to on-pathway oligomers through the switching pathways due
to the dilution of the system. The EKS simulations were conducted in the same way as the
experimental set-up. For the off-to-on switching (figure 6), first, combined off- and on-pathway
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Figure 6. Correspondence between experimental results and EKS models on switching of pathways. (a) and (b) Experimental data
(scatter data) on on-to-off and off-to-on pathways reproduced from figure 5b and f, respectively. Models based on EKS are shown as
black lines. The intervention time points of 3 and 24 h (for (a)), and 5 and 24 h (for (b)) are shown as arrows. Panel (c) shows a
phase diagram from EKS model at saturation, similar to figure 4 based on variations of the first two bridges. Here, the oligomer ratio
of on-pathway to off-pathway was plotted as a heatmap (brighter colour, yellow, denotes on-pathway dominance while darker
colour, blue, denotes off-pathway dominance) where the x-axis is bridge rate constant kcon and y-axis is switching rate
constant kswi. The phase diagram shows a dominance of on-pathway at low values of kswi and kcon and dominance of off-
pathway for high values of kswi and kcon.
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simulations were executed, up to the switching time-point (of 5 or 24 h); all oligomer concentrations
were noted until this point and they were then recalculated based on the amount of dilution at the
switching time-point from the experiments. These altered concentration levels for each oligomer
were next considered as the initial concentration of the combined off- and on-pathway simulation.
Note that the second phase of the off-to-on dataset (figure 6a) did not show any lag time as can be
seen in a usual unseeded on-pathway aggregation. Our model predicts a large conversion of off-
pathway species to on-pathway oligomers which results in a rapid formation of on-pathway fibrils
(denoted by F ).
For the on–off dataset (figure 6b), stand-alone on-pathway simulations were executed exclusively up
to the switching time-point (24 h) and the current oligomer concentrations were noted. These
concentrations were then used to restart the combined on- and off-pathway simulation in addition to
the pseudo-micelle concentration (that was also estimated in the parameter search step as an
independent variable). Surprisingly, we found that the on-to-off-pathway dataset could be fit to our
model both considering the switching rate constants, and also in the absence of switching rate
constants generating comparable R2 values; in other words, the switching rate constants had low
sensitivity to the on–off experimental dataset. Probably as the on-pathway reactions are slow, very
little on-pathway oligomers are formed at the switching time-point; as a consequence, this made
the switching reaction flux slower than the previous case of off–on switching system resulting
in overall lower sensitivity of the switching rate constants to the ThT data points from the
experiments. While this precludes precise characterization of on–off switching, we do observe an
overall decrease in fibril concentration compared with control data showing at least a qualitative
impact of the switching reactions that convert the on-pathway oligomers into off-pathway species.
Furthermore, we have also compared the phase diagram of the EKS model by plotting the oligomer
ratio of on-pathway to off-pathway (as a heatmap) with varying bridge parameters and
switching parameters during the saturation phase (75 h) (figure 6c). The total oligomer count scaled
by their size from each pathway was used to compute this ratio. In this heatmap, brighter
colour (yellow) denotes a dominance of on-pathway, whereas darker colour (blue) denotes a
dominance of off-pathway. By doing so, four phases similar to those obtained from ROM were
observed. For a low bridge and switching parameters, a dominance of on-pathway species was
observed, whereas for a high value of bridge and switching parameters a prevalent off-pathway was
observed (figure 6c); the light yellow and light blue regions depict the mixed pathway zones where
both on- and off-pathway oligomers coexist. Note that a one-to-one correspondence between the
phase diagrams generated from EKS and ROM models is not possible since the EKS models were
built considering a detailed set of reactions, whereas the ROM models correspond to more bulk
reactions involving fewer species.
4. Discussion
The data presented here is a first attempt in deciphering the complex phenomenon of protein aggregation
pathways using a competition-based approach based on classical game theory. Aberrant protein
aggregation is sensitive to environmental factors that determine the outcome of the aggregates [38,49].
Using the Aβ-fatty acid model system, we have employed a competition-based framework on
simplified ROMs to gain preliminary insights. The results re-confirmed our previous observation that
fatty acid concentrations modulate Aβ aggregation pathways [34]. Additionally, we discovered that the
adoption of on- or off-pathway aggregates tightly depends on a set of rate constant ratios, which in
turn suggest the thermodynamic stability (equilibrium constants) of the emerging aggregates.
Moreover, α parameters are sensitive to the pseudo-micellar surfactant concentrations, L, which hold
the key in modulating pathways. The models also provide insights into the feasibility of bridging
pathways as a function of emerging higher-order aggregates. For example, the reduced order, six-
species model predicts four different scenarios or dominant pathways of reactions which are strongly
dependent upon the bridge, while also suggesting that α4 is the key to the formation of larger
aggregates in off-pathway. Stability arguments also show the larger aggregates in this system to be
more stable (see Appendix B). The EKS simulations display a similar outcome; the simulations
indicate that the larger the oligomer, the more significant the impact of that bridge upon formation of
the respective fibril.
In our experiments, we note that the propensity to switch pathways is highest when the order of
aggregate is the lowest (low-molecular weight) and increasingly becomes weaker as we move toward
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higher-order aggregates along either pathway. This is in agreement with the theoretical studies noting the
fact that in experiments, high molecular weight species refer to fibrils, while low-molecular weight
aggregates then refer to the range of oligomers taken up in EKS and ROM simulations. Perhaps, a
significant outcome of this study is the ability of the model to predict the emergence of oligomers by
a set of kinetic and thermodynamic parameters, from a ‘win’ or ‘lose’ perspective (figure 4). Another
key observation is the presence of multiple (neutrally) stable pathways in addition to simplistic on-
and off-pathways (figure 4; see Appendix B). The hybrid pathways, especially the off–on domain
shown in yellow in figure 4, provide a range of possibilities for α3 and α4 to draw the aggregation
dynamics away from toxicity. This is particularly significant for possible intervention strategies,
pointing new lines of experimental and theoretical inquiries in the future. Numerical simulations and
experiments both clearly support this qualitative result (figures 5 and 6), by revealing dilution to be a
clear strategy to force the off–on transition.
Results of ROM indicate that when the ratio of non-bridge forward to backward rates is close to unity,
the model achieves equilibrium quickly. However, when forward rates are considerably higher than
backward rates, as is to be expected under normal circumstances, the system takes considerably
longer to achieve equilibrium due to a cycle of over-shooting of species sizes resulting from a large
difference in reaction rates. Similarly, corresponding EKS simulations indicate a 1018-fold difference in
the forward and backward switching rate constants (table 2 in Appendix C) pointing to potentially
irreversible effects of switching oligomers between pathways although the system may take a longer
time to achieve equilibrium; this observation, however, pertains to our reaction system with fixed
initial monomer concentration and is expected to show fluctuating dynamics by considering monomer
or pseudo-micelle entry rates and stochastic effects of the switching of oligomers between the pathways.
5. Conclusion
The results presented here showcase the applicability of game theory on understanding amyloid
aggregation pathways. This is significant because it provides an ability to predict the emergence of
aggregates along multiple pathways along a temporal and equilibrium landscape map. Such a map
can be further refined to see how it evolves as a function of a given interacting partner of Aβ, such as
fatty acid as demonstrated here. A significant impact of this work could be realized with the potential
for the prediction of the emergence of oligomers, which provides a handle for understanding the
conditions at which toxic strains are formed and disappear. The simplified model presented here can
be further fine-tuned into more sophisticated models by including more species along pathways,
additional pathways and more interacting partners that can modulate the pathway, etc. In sum, the
results presented here establish a new paradigm in understanding the complex dynamics of Aβ
aggregation and provide impetus towards deciphering amyloid pathogenesis along with making
therapeutic and diagnostic advances for such debilitating diseases in the future.
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Appendix A. Choice of n and m in reduced-order model
The approach taken up in this paper and in our previous research papers as well is to break up the
complex problem of protein aggregation to a more tractable and analysable form, via the reduced-
order model and also the larger, EKS model which lends itself to the details of the biophysics. The
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ROM is, therefore, to be seen as a toy problem, which permits detailed analysis in a manner not possible
with the very complex EKS model, where the parameters are all fixed (obtained through curve fitting
with the experimental results). The results of the ROM provide insights into the system and help us
ask the right kinds of questions about the kinds of experiments and EKS computations that needed to
be performed. While some of the figures in the main text are restricted to the case n = 4, m = 20, these
choices are made without loss of generality. Other choices of n and m (figure 7) have also been
explored and the outcomes are seen to be qualitatively very similar to the one shown. Figure 7 shows
the change in the % of the phase space (0 <∝ 3 < 2, 0 <∝ 4 < 2) taken up by each of the four pathways
with changes to the pair (n, m). The bar graphs reveal these phases to barely change showing their
ubiquity and theoretical significance. Appendix B, which focuses on the stability analysis of the
system also reveals similar results.
Appendix B. Linear stability analysis of reduced-order model
A linear stability analysis was conducted to confirm the conditions under which equilibria are stable and
the sensitivity of these solutions to the parameters in this problem. We use the variables X1, Y1, Xn, Yn, Xm
and Ym to represent the concentrations of the various perturbed species, while the equilibria for the
monomers and oligomers from the two pathways are indicated by means of an ‘e’ in the subscript
(i.e. Bk,e represents the equilibrium concentration for the oligomer of size k). The central idea behind
the stability analysis being that a stable equilibrium requires that the perturbed quantities eventually
vanish, under certain conditions.
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The linearized system of equations for the perturbations yields the matrix, given by
ðn2a2Bn11,e þa3Þ 1 na1 0 0 0
a3 ðn2b2Bn11,e þ1Þ 0 nb1 0 0
na2Bn11,e 0  a1þa4þ
m2
n
b3B
ðm=nÞ1
n,e
 
b4
m
n
a5 0
0 nb2B
0n1
1,e a4  b1þ
m2
n
a6B0ðm=nÞ1n,e þb4
 
0
m
n
b5
0 0
m
n
b3B
ðm=nÞ1
n,e 0 a5 0
0 0 0
m
n
a6B0ðm=nÞ1n,e 0 b5
0
BBBBBBBBBBBBBBB@
1
CCCCCCCCCCCCCCCA
ðB1Þ
whose eigenvalues (denoted λi, where i = 1–6) are indicative of the stability of the systems. Of key interest
is the effect of the bridge parameters, α3 and α4, and their effect on the stability of each model. A sampling
of this effect is captured in figure 8, which depicts the contour plots of the eigenvalues of the Base Model
for 0≤ α3, α4≤ 2 for the special case when n = 8 and m = 40. In this figure, the lighter shades depict regions
of low stability while the darker ones are more stable. The eigenvalue λi corresponds to neutral stability.
Overall, we find that the stability profile for equilibria corresponding to the Base Model does not change
much for variations in values of n and m. The stability picture for the Base Model, however, is significantly
different from that of Model 2. In the Base Model, one of λ4 or λ5, is always zero for all values of α3 and α4,
while for Model 2, we observe switching behaviour between λ2 and λ4, i.e. Model 2 shows greater
sensitivity to the values of the bridge parameters.
We distinguish two different characteristic effects, namely switching and crossing of the eigenvalues as
the two bridge parameters are varied (figure 9). The switching indicates a sudden, drastic change in
behaviour of the species, where the course of domination of one species over other is abruptly reversed
while the crossing is a more gradual version of this shift. In previous work [34], the switching has been
compared with a sort of transcritical-like bifurcation in the system. Table 1 shows the switching and
crossing points for eigenvalues λ1 and λ2 as α3 and α4 vary. As can be seen, there is crossing where α3=
α4, whereas switching has an exponential relationship between the two parameters. A regression model
indicates that switching occurs according to a42:041:55a3 with R2 = 0.953.
Simulations for other reaction rate regimes over a larger range of values for α3 and α4 (greater than 2)
showed the switching and crossing to persist, as indicated by table 1. In previous studies with lower-
dimensional models [34], we have seen such switching to occur as well, which appears to be indicative
of the sensitivity of the system to the various pathways and species in the model and activation of one of
these pathways under appropriate conditions. For the Base Model, with n = 2 and m = 4, we have λ3 = 0
for low α3 and α4, but as we increase these two parameters, λ2 vanishes and then finally, with further
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Figure 8. λi as a function of α3 and α4 for the case of n = 8, m = 40. The deeper blue shade represents the more stable regions.
The eigenvalue λ4 is 0 for all values of the parameters indicating neutral stability.
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increase, λ4 goes to zero. Thus, for any rate environment, the stability of the system near the point of
equilibrium was found to be neutrally stable for sufficiently large values of the bridge parameters.
The impact of species-size upon stability was also examined by studying the cases of (n, m) equal to
(2, 4) and (8, 40) in addition to the standard case (4, 20). Overall, in the case of the Base Model, no
switching of eigenvalues was observed for a given species size environment as α3 and α4 were varied.
For instance, in the Base Model, λ5 is zero for all values of α3 and α4 when n = 2 and m = 4, and λ4
is zero when n = 8 and m = 40. However, for Model 2, there is switching between λ2, λ3 and λ4 when
n = 2 and m = 4, whereas when n = 8 and m = 40, we observe switching between λ1, λ2 and λ3. In
general, as n and m are increased, the overall magnitude of stability increases, i.e. the larger the species,
the more stable the individual oligomer and also the overall system, appears to be.
Appendix C. The ensemble kinetic simulation model
Differential equations of the species:
On-pathway species:
dA1
dt
¼ I1
X11
i¼1
Hi H1,
dAi
dt
¼ Hi þH(i1)  Ii; 8i [ {2, 3},
dAi
dt
¼ Hi þH(i1)  Ii þ Si; 8i [ {4, . . . ,11}
and
dF
dt
¼ H11:
Table 1. The switch and cross points of α3 as a function of α4.
switch cross
α4 α3 α3
2 0.90 2
4 1.53 4
8 2.35 8
16 4.05 16
32 6.65 32
64 8.05 64
–1
–2
–3
ei
ge
nv
al
ue
s
–4
l1
a3
l2
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0 1 2 3 4
Figure 9. A sample case of eigenvalues depicting switching and crossing as a function of the bridge parameter α3. The eigenvalue
λ2 is denoted in blue while eigenvalue λ1 is indicated in lavender.
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Off-pathway species:
dA04
dt
¼ G01 H01  I01  S4,
dA0i
dt
¼ H0i þH0(i1)  I0i  Si; 8i [ {5, . . . ,11},
dF01
dt
¼ H011  P01 
X3
i¼1
P0i,
dF0i
dt
¼ P0i1  P0i; 8i [ {2, . . . ,3},
dF04
dt
¼ P03  R01
and
dF001
dt
¼ 4R01:
Pseudo-micelle
dL
dt
¼G01
The simulated signal calculated as follows:
signalon ¼ [F]  p,
signaloff ¼
X4
i¼1
F0i ; 8i [ {1, . . . ,4}
and signal ¼ signalon þ signaloff:
The estimated parameters are given in table 2.
Table 2. Estimated parameters from the EKS model.
parameters value
knu 4 × 10
−4 µM−1 h−1
knu 3.5 × 10
−2 h−1
kel 3.5 × 10
5 µM−1 h−1
kel 1 × 10
−3 h−1
kcon 5 × 10
−6 µM−3 h−1
kcon 1 × 10
−1 h−1
knuf 1.4 × 10
−1 µM−1 h−1
knuf 1 h
−1
kel1f 1 × 10
4 µM−1 h−1
kel1f 2 × 10
−1 h−1
kel2f 1 × 10
3 µM−1 h−1
kel2f 5 × 10
−3 h−1
kfagf 5 × 10
3 h−1
k fagf 6 × 10
−7 µM−3 h−1
kswi 5 × 10
15 h−1
kswi 1 × 10
−3 h−1
p 2 × 108/8 × 108
L 50 µM
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